Condition
Ovary; Anomaly
Total Trials
4
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 2 (2)
Trial Status
Recruiting2
Terminated1
Unknown1
Clinical Trials (4)
Showing 4 of 4 trials
NCT05181748Phase 2Recruiting
Autologous Platelet Rich Plasma Intraovarian Infusion for Poor Responders
NCT03937661Phase 2RecruitingPrimary
Autologous Platelet-Rich Plasma Intra-ovarian Infusion in Poor Responders
NCT04178018Not ApplicableTerminatedPrimary
Transvaginal Ultrasound and Photoacoustic Imaging of Ovary
NCT03649087Not ApplicableUnknownPrimary
Vitrification for Ovarian Tissue Harvesting
Showing all 4 trials